Pfizer: Vaccine is not the only measure to contain covid-19 6:15
(CNN) -
Pfizer and BioNTech announced Friday that the U.S. Food and Drug Administration (FDA) has granted priority review designation to companies' application for approval of their vaccine. against covid-19.
The target date for an FDA decision is January 2022, the companies said.
The typical priority review process is scheduled for six months, but FDA approval could come before the target date.
Andy Slavitt, a former White House senior adviser for COVID-19 response, told CNN earlier this month that approval could come in July, but acknowledged that it is a complex process.
5 Questions After Pfizer's Vaccine Decreased Effectiveness Announcement
"There are a lot of moving pieces. It's not that easy," Slavitt told CNN's Alisyn Camerota.
"I hope that in the next four or five weeks, and I think it will be very, very good news."
Pfizer and BioNTech completed the submission of the biological license application for the vaccine for people over 16 years of age in May.
News in development ...
advertising
covid-19 vaccine